UI Hospitals and Clinics

Clinical Trial Details

Short Title
Official Title

Efficacy and safety of liraglutide in combination with metformin versus metformin monotherapy on glycemic control in children and adolescents with type 2 diabetes.  A 26-week double-blind, randomized, parallel group, placebo controlled multi-center trial followed by a 26-week open-label extension


UIHC Department of Pediatrics/Division of Endocrinology are inviting children between the age of 10-17 years who have been diagnosed with type 2 diabetes to participate in a research study testing an investigational medicine called liraglutide.  Call 1-866-309-0837 if interested. Compensation av

Start Date
October 15, 2013
End Date
October 15, 2015
Gender Preference
Age Group
10 - 17 years
Principal Investigator
Eva Tsalikian, MD
Contact Info

Sarah Salamati 1-866-309-0837 sarah-salamati@uiowa.edu

diabetes ; liraglutide ;

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.